Arterial Blood Sampling Systems

Arterial Blood Sampling Systems Market Outlook

The global arterial blood sampling systems market is expected to reach approximately USD 1.5 billion by 2035, growing at a CAGR of 6.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing demand for blood sampling procedures for various diagnostic purposes, advancements in medical technology, and the rising prevalence of chronic diseases and conditions that require regular monitoring. Additionally, the growing emphasis on patient safety and the development of innovative blood sampling techniques are also significantly contributing to the market expansion. Increased healthcare expenditures and the integration of automated blood sampling systems into clinical practice further drive the market forward. As healthcare systems evolve, the need for more efficient and less invasive blood sampling methods continues to gain prominence.

Growth Factor of the Market

The arterial blood sampling systems market is experiencing significant growth due to several key factors. One of the primary drivers is the increasing incidence of respiratory disorders and metabolic diseases, which necessitate regular blood analysis for monitoring patients' health status. Furthermore, the ongoing advancements in medical technologies, such as needle-free devices and microsampling techniques, are transforming traditional blood sampling practices into safer and more efficient procedures. The growing focus on personalized medicine and targeted therapies also underpins the demand for precise and accurate blood sampling systems. Additionally, the rising number of healthcare facilities, particularly in emerging economies, is bolstering the market as access to quality diagnostic services continues to improve. Coupled with the increasing awareness among patients regarding the importance of routine blood analysis, the factors collectively contribute to the robust growth of the arterial blood sampling systems market.

Key Highlights of the Market

• The global arterial blood sampling systems market is projected to witness a CAGR of 6.5% from 2025 to 2035.
• Innovations in blood sampling technology, such as microfluidics, are revolutionizing the industry.
• North America holds a significant market share, driven by advanced healthcare infrastructure.
• Growing focus on patient safety is leading to the adoption of less invasive blood sampling methods.
• The increasing prevalence of lifestyle-related diseases is driving demand for frequent blood testing.

By Product Type

Needle and Syringe Systems:

Needle and syringe systems remain the most commonly used method for arterial blood sampling due to their simplicity and reliability. These systems allow for direct access to arterial blood, making them suitable for various tests, including blood gas analysis and biochemical profiles. The affordability and availability of these systems further enhance their market penetration. However, the need for skilled personnel to perform these procedures safely poses a limitation. Despite this, advancements in needle design, such as safety-engineered needles, have improved safety and comfort, ultimately sustaining the demand for needle and syringe systems in the healthcare sector.

Catheter Systems:

Catheter systems are specifically designed for arterial blood sampling in critical care settings where frequent access to arterial blood is necessary. These systems are capable of continuous blood sampling and monitoring, making them vital for patients in intensive care units (ICUs) and surgical settings. Although catheter systems can be more expensive than traditional needle and syringe methods, their advantages in terms of reduced discomfort and increased patient safety are driving their adoption. The growing number of surgeries and critical care procedures is expected to further propel the demand for catheter systems in the arterial blood sampling market.

Microsampling Systems:

Microsampling systems are an emerging alternative providing a less invasive approach to blood collection. These systems allow for smaller blood volumes, making them particularly useful for pediatric patients, geriatric patients, and those with difficult venous access. The rise in demand for point-of-care testing and home healthcare solutions has further stimulated the growth of microsampling systems, as they offer convenience and minimal invasiveness. Continuous advancements in technology are enabling the development of more efficient microsampling devices, which is likely to enhance their adoption in the coming years.

Capillary Systems:

Capillary systems utilize fingerstick or heelstick methods for blood sampling, allowing for quick and easy access to blood without the need for venous access. These systems are predominantly used for glucose monitoring and in pediatric patients. The convenience of capillary blood sampling is a significant advantage, particularly in home care settings, where patients can perform their tests with minimal assistance. The increasing prevalence of diabetes and other chronic diseases that require regular monitoring is driving the demand for capillary systems, ensuring their continued growth in the arterial blood sampling market.

Lancet Systems:

Lancet systems are designed for small blood sample collection, often used in conjunction with capillary systems. These devices facilitate easy and less painful blood collection, making them ideal for patients who require frequent testing, such as those with diabetes. The growing awareness of self-monitoring blood glucose levels among diabetic patients enhances the demand for lancet systems. Moreover, the development of advanced lancet designs that reduce pain and improve safety further supports market growth. The increasing emphasis on point-of-care testing is also contributing to the rising adoption of lancet systems across various healthcare settings.

By Application

Blood Gas Analysis:

Blood gas analysis is a critical application for arterial blood sampling systems, particularly in emergency and critical care settings. This analysis provides essential information regarding a patient's oxygen and carbon dioxide levels, as well as their acid-base balance. Given the rising number of patients with respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, the demand for blood gas analysis is expected to grow significantly. As healthcare evolves towards more accurate and immediate diagnostic processes, the importance of arterial blood gas analysis in monitoring and treating patients will remain a substantial driver of market growth.

Blood Chemistry Analysis:

Blood chemistry analysis involves the examination of various chemical substances in the blood, which can indicate the presence of underlying conditions such as diabetes, liver disease, and kidney dysfunction. The increasing prevalence of chronic diseases and the need for routine health check-ups are propelling the demand for blood chemistry analysis. Arterial blood sampling systems are crucial in ensuring accurate and timely results, which are essential for effective patient management. Moreover, advancements in laboratory technology and automation are further enhancing the efficiency of blood chemistry testing, thus contributing to the growth of the market.

Blood Culture Analysis:

Blood culture analysis is instrumental in diagnosing bloodstream infections and sepsis, making it an essential application of arterial blood sampling systems. The rising incidence of infectious diseases and the growing awareness of sepsis-related complications are driving the demand for blood culture testing. Arterial blood provides more accurate and reliable results compared to venous blood; consequently, healthcare providers increasingly rely on arterial blood sampling systems for this purpose. The development of rapid culture techniques is also enhancing the efficiency of blood culture analysis, further supporting market growth in this segment.

Coagulation Testing:

Coagulation testing is vital for assessing the blood's ability to clot, and it plays a crucial role in managing patients on anticoagulation therapy. With the increasing number of surgeries and diagnostic procedures that require coagulation assessments, the demand for arterial blood sampling systems is expected to rise. These systems enable healthcare professionals to obtain accurate coagulation parameters, thereby informing treatment decisions and improving patient outcomes. Furthermore, the advancement of point-of-care coagulation testing devices is facilitating rapid diagnosis, which will consequently drive the growth of the market for arterial blood sampling systems.

Others:

The 'Others' category encompasses a variety of applications that require arterial blood sampling systems, including routine check-ups and specialized tests. As healthcare providers seek to enhance patient care and improve diagnostic accuracy, there is a growing need for versatile blood sampling systems that can accommodate various testing applications. This segment also benefits from the increasing emphasis on preventive healthcare, as more patients undergo routine monitoring and screening for early detection of diseases. Consequently, the demand for arterial blood sampling systems across diverse applications is expected to contribute significantly to market growth.

By Distribution Channel

Hospitals:

Hospitals represent a significant distribution channel for arterial blood sampling systems, given their central role in patient care and diagnostics. Most arterial blood sampling procedures are performed in hospitals, where access to specialized equipment and trained personnel is readily available. The rising number of hospital admissions due to chronic diseases and emergencies increases the demand for efficient blood sampling systems. Additionally, hospitals are increasingly investing in advanced technologies that enhance patient safety and improve diagnostic accuracy, further driving the market for arterial blood sampling systems in this segment.

Clinics:

Clinics, including outpatient and specialty clinics, play a vital role in the arterial blood sampling systems market. Many patients seek healthcare services in clinics for routine check-ups and minor procedures, leading to a growing demand for blood sampling services. The adoption of point-of-care testing devices in clinics allows for expedient blood sampling and immediate results, thereby improving patient satisfaction and outcomes. As clinics continue to expand their diagnostic capabilities and services, the demand for arterial blood sampling systems will also see a corresponding increase, contributing positively to market growth.

Diagnostic Centers:

Diagnostic centers are specialized facilities that focus on laboratory testing and diagnostics, creating a significant distribution channel for arterial blood sampling systems. The growing trend of outsourcing laboratory services to dedicated diagnostic centers enhances the demand for reliable blood sampling methods. As patients increasingly seek specialized testing services, these centers are investing in advanced arterial blood sampling technologies that allow for accurate and efficient testing. Furthermore, the rising awareness of preventive healthcare and early detection of diseases is driving patient visits to diagnostic centers, leading to increased utilization of arterial blood sampling systems.

Homecare Settings:

The demand for arterial blood sampling systems in homecare settings is on the rise, driven by the increasing trend of telemedicine and remote patient monitoring. Patients with chronic diseases, such as diabetes and hypertension, benefit from home blood sampling solutions that allow them to manage their health proactively. The availability of user-friendly blood sampling devices that can be used at home encourages patient compliance and improves health outcomes. As healthcare providers continue to embrace homecare models, the demand for arterial blood sampling systems designed for at-home use is expected to grow significantly.

Others:

The 'Others' category includes various distribution channels for arterial blood sampling systems, such as research laboratories and educational institutions. As the need for blood sampling systems extends beyond clinical applications, the demand from these sectors is steadily increasing. Research laboratories require reliable blood sampling methods for studies related to disease mechanisms and treatment efficacy. Educational institutions that offer training programs in healthcare also need these systems for hands-on learning experiences. The diversification of distribution channels is likely to enhance overall market growth for arterial blood sampling systems.

By Material Type

Plastic:

Plastic materials are widely used in the manufacturing of arterial blood sampling systems due to their lightweight, flexibility, and cost-effectiveness. Many disposable blood sampling devices, including syringes, tubes, and collection bags, are predominantly made from plastic, ensuring ease of use and reducing the risk of cross-contamination. The growing emphasis on safety and hygiene, particularly in healthcare environments, drives the demand for single-use plastic blood sampling devices. Additionally, the continuous advancements in plastic materials, such as the development of safer and more durable options, are expected to support market growth in this segment.

Glass:

Glass materials have been traditionally used in blood sampling systems, especially for laboratory collection tubes and vials, as they are inert and provide excellent protection against contamination. The accuracy and integrity of samples collected in glass containers are paramount, which is driving their continued use in specific applications. Although the market for glass blood sampling devices is witnessing challenges due to the rise of plastic alternatives, the demand for glass remains steady in specialized laboratory settings where sample integrity is vital. Additionally, advancements in glass technology are enhancing the safety and usability of glass blood sampling systems.

Metal:

Metal materials are primarily utilized in the design of certain arterial blood sampling systems, particularly in the production of needles and lancets. Metal components offer durability and precision, which are essential for effective blood sampling procedures. The market for metal-based blood sampling devices is stable, with increasing innovations focused on improving needle design to enhance patient comfort and safety. Furthermore, the growing awareness of the importance of secure and reliable blood sampling processes supports the demand for metal components in arterial blood sampling systems.

Silicone:

Silicone materials are increasingly being integrated into arterial blood sampling systems, particularly for components that require flexibility and resilience. Silicone's biocompatibility and resistance to chemical degradation make it an excellent choice for certain medical applications, such as tubing and seals in blood sampling devices. As the demand for safer and more effective blood sampling alternatives continues to grow, silicone-based systems are expected to gain traction in the market. The versatility and adaptability of silicone materials present numerous opportunities for innovation in arterial blood sampling technologies.

Others:

The 'Others' category encompasses various material types used in arterial blood sampling systems, including composites and advanced polymers. These materials are often designed to meet specific requirements, such as enhanced safety features or improved sample stability. As research and development in the field of medical materials continue to progress, the demand for innovative solutions that address the growing need for patient safety and comfort is likely to expand. The emergence of novel materials in the arterial blood sampling market will contribute to the overall growth of the sector.

By Region

The North American region holds a significant share of the arterial blood sampling systems market, driven by advanced healthcare infrastructure, high healthcare expenditures, and a well-established network of hospitals and diagnostic centers. The increasing prevalence of chronic diseases, coupled with the demand for accurate and efficient blood sampling methods, is propelling market growth in this region. Moreover, the rising adoption of innovative technologies in medical devices, such as needle-free blood sampling systems, is expected to further boost market dynamics. North America is projected to grow at a CAGR of 6.0% during the forecast period, reflecting the strong demand for arterial blood sampling systems across various healthcare settings.

In Europe, the arterial blood sampling systems market is also witnessing robust growth, primarily due to the increasing emphasis on patient safety and the development of advanced blood sampling technologies. The rising incidence of lifestyle-related diseases, such as diabetes and cardiovascular disorders, is driving healthcare providers to adopt more efficient blood sampling solutions. Additionally, government initiatives aimed at improving healthcare access and quality are contributing to the positive outlook for the market. The European market is anticipated to grow at a CAGR of 7.0% from 2025 to 2035, underscoring the region's significant potential for arterial blood sampling system adoption.

Opportunities

The arterial blood sampling systems market presents numerous opportunities for growth as healthcare systems evolve and patient needs change. One significant opportunity lies in the development of innovative, less invasive blood sampling devices. As patients increasingly prefer comfort and convenience, manufacturers can invest in research and development to create systems that minimize discomfort and reduce the risk of complications. The rise of telemedicine and remote monitoring also opens avenues for home-based blood sampling solutions that enable patients to manage their health more proactively. Innovations in technology, such as the use of microfluidics and automated blood sampling devices, can further enhance market prospects and offer improved patient experiences.

Moreover, expanding healthcare access in emerging economies presents a substantial opportunity for the arterial blood sampling systems market. As healthcare infrastructure improves and the availability of diagnostic services increases, the demand for efficient blood sampling solutions will rise. Moreover, the growing awareness of preventive healthcare and early disease detection will drive the need for regular blood sampling procedures in these regions. By strategically targeting emerging markets, key players in the arterial blood sampling systems industry can capitalize on increasing healthcare expenditures and tap into a larger customer base, ultimately driving market growth.

Threats

The arterial blood sampling systems market faces several threats that could potentially hinder its growth. One of the primary concerns is the increasing competition from alternative blood sampling methods, such as non-invasive techniques that utilize advanced technologies for blood analysis. As healthcare providers and patients seek more comfortable and less invasive solutions, traditional arterial blood sampling methods may come under pressure. Additionally, regulatory challenges related to the approval and commercialization of new blood sampling devices can impede market growth, as prolonged approval timelines can delay the introduction of innovative products. Furthermore, price sensitivity in certain geographical regions may limit the adoption of advanced blood sampling systems, ultimately affecting overall market revenues.

Another significant threat to the arterial blood sampling systems market is the potential risk of adverse events and complications arising from blood sampling procedures. Concerns over patient safety and the occurrence of infections, hematomas, or other complications can lead to negative perceptions of traditional blood sampling methods. This could result in reduced demand for these systems as healthcare providers may seek to adopt safer alternatives. Additionally, the ongoing global healthcare challenges, such as economic instability and the impact of pandemics, may disrupt supply chains and affect the availability of blood sampling devices, posing further threats to the market's growth potential.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Terumo Corporation
• Abbott Laboratories
• Roche Holding AG
• Greiner Bio-One International GmbH
• Smiths Medical
• Fisher Scientific
• Medtronic plc
• HemoCue AB
• Cardinal Health, Inc.
• Hemocue
• Shandong Weigao Group Medical Polymer Co., Ltd.
• Vyaire Medical, Inc.
• Hologic, Inc.
• MicroPort Scientific Corporation

The competitive landscape of the arterial blood sampling systems market is characterized by several key players who are continually striving to enhance their product offerings and capture a larger market share. Companies such as BD, Terumo Corporation, and Abbott Laboratories are leading the industry with their extensive portfolios of arterial blood sampling devices. These organizations are investing heavily in research and development to innovate and improve existing products, ensuring they remain competitive in the rapidly evolving healthcare environment. Additionally, collaborations and partnerships between manufacturers and healthcare providers are playing a crucial role in the development of advanced blood sampling technologies that cater to the evolving needs of patients and healthcare professionals.

Furthermore, the market is witnessing a trend toward consolidation as companies seek to enhance their capabilities through mergers and acquisitions. This strategy allows businesses to expand their reach, enhance their product offerings, and achieve greater operational efficiencies. Key players are also focusing on expanding their presence in emerging markets where there is growing demand for effective blood sampling solutions due to increasing healthcare access and rising disease prevalence. By leveraging these strategies, companies can position themselves for success and maintain a competitive edge in the arterial blood sampling systems market.

Among the major companies in this sector, BD (Becton, Dickinson and Company) stands out as a frontrunner with its comprehensive range of blood sampling products and solutions. BD has made significant investments in advanced manufacturing technologies that allow it to produce high-quality and reliable blood sampling devices. The company's dedication to innovation is reflected in its continuous efforts to develop new products that meet the changing needs of healthcare providers and patients. Terumo Corporation, another major player, has a strong reputation for its advanced blood collection systems that emphasize patient safety and comfort, positioning itself as a trusted choice among healthcare professionals. Abbott Laboratories, known for its diagnostic products, also plays a significant role in the arterial blood sampling market with its innovative solutions that ensure accurate and timely test results.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Hemocue
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 HemoCue AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smiths Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Holding AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fisher Scientific
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Vyaire Medical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cardinal Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 MicroPort Scientific Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Greiner Bio-One International GmbH
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shandong Weigao Group Medical Polymer Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Arterial Blood Sampling Systems Market, By Application
    • 6.1.1 Blood Gas Analysis
    • 6.1.2 Blood Chemistry Analysis
    • 6.1.3 Blood Culture Analysis
    • 6.1.4 Coagulation Testing
    • 6.1.5 Others
  • 6.2 Arterial Blood Sampling Systems Market, By Product Type
    • 6.2.1 Needle and Syringe Systems
    • 6.2.2 Catheter Systems
    • 6.2.3 Microsampling Systems
    • 6.2.4 Capillary Systems
    • 6.2.5 Lancet Systems
  • 6.3 Arterial Blood Sampling Systems Market, By Material Type
    • 6.3.1 Plastic
    • 6.3.2 Glass
    • 6.3.3 Metal
    • 6.3.4 Silicone
    • 6.3.5 Others
  • 6.4 Arterial Blood Sampling Systems Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Diagnostic Centers
    • 6.4.4 Homecare Settings
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Arterial Blood Sampling Systems Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Arterial Blood Sampling Systems market is categorized based on

By Product Type

• Needle and Syringe Systems
• Catheter Systems
• Microsampling Systems
• Capillary Systems
• Lancet Systems

By Application

• Blood Gas Analysis
• Blood Chemistry Analysis
• Blood Culture Analysis
• Coagulation Testing
• Others

By Distribution Channel

• Hospitals
• Clinics
• Diagnostic Centers
• Homecare Settings
• Others

By Material Type

• Plastic
• Glass
• Metal
• Silicone
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Terumo Corporation
• Abbott Laboratories
• Roche Holding AG
• Greiner Bio-One International GmbH
• Smiths Medical
• Fisher Scientific
• Medtronic plc
• HemoCue AB
• Cardinal Health, Inc.
• Hemocue
• Shandong Weigao Group Medical Polymer Co., Ltd.
• Vyaire Medical, Inc.
• Hologic, Inc.
• MicroPort Scientific Corporation